First Patient Dosed in Phase II Basket Trial of Taletrectinib for Solid Tumors with NTRK Fusion
Go back to First Patient Dosed in Phase II Basket Trial of Taletrectinib for Solid Tumors with NTRK Fusion(AMEX: IVBIY) | Delayed: 18.66 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $18.66 | 52 Week High | $ | |||
Open | $18.66 | 52 Week Low | $ | |||
Day High | $18.66 | P/E | N/A | |||
Day Low | $18.66 | EPS | $ | |||
Volume | 11,170 |